Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Exchange Rate Effect: 2016-2024

Historic Exchange Rate Effect for Mereo BioPharma Group (MREO) over the last 9 years, with Dec 2024 value amounting to -$233,000.

  • Mereo BioPharma Group's Exchange Rate Effect fell 134.72% to -$418,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $657,000, marking a year-over-year decrease of 75.75%. This contributed to the annual value of -$233,000 for FY2024, which is 108.27% down from last year.
  • Mereo BioPharma Group's Exchange Rate Effect amounted to -$233,000 in FY2024, which was down 108.27% from $2.8 million recorded in FY2023.
  • Mereo BioPharma Group's 5-year Exchange Rate Effect high stood at $2.8 million for FY2023, and its period low was -$12.6 million during FY2022.
  • In the last 3 years, Mereo BioPharma Group's Exchange Rate Effect had a median value of -$233,000 in 2024 and averaged -$3.3 million.
  • As far as peak fluctuations go, Mereo BioPharma Group's Exchange Rate Effect plummeted by 701.18% in 2022, and later spiked by 122.40% in 2023.
  • Yearly analysis of 5 years shows Mereo BioPharma Group's Exchange Rate Effect stood at -$987,508 in 2020, then tumbled by 59.03% to -$1.6 million in 2021, then slumped by 701.18% to -$12.6 million in 2022, then soared by 122.40% to $2.8 million in 2023, then tumbled by 108.27% to -$233,000 in 2024.